Zydus gets USFDA nod for generic drug to treat stomach & esophagus problems
Zydus Lifesciences on Thursday said it has received approval from the US health regulator to market a generic drug used to treat certain stomach and esophagus problems.
Zydus Lifesciences on Thursday said it has received approval from the US health regulator to market a generic drug used to treat certain stomach and esophagus problems.
The company has received approval from US Food and Drug Administration (USFDA) to market Esomeprazole Magnesium for delayed-release oral suspension in 20 mg and 40 mg strengths in the American market, the drug maker said in a statement.
Esomeprazole is used to treat certain stomach and esophagus problems such as acid reflux and ulcer. It works by reducing the amount of acid the stomach makes and providing relief from symptoms such as heartburn, difficulty swallowing, and cough.
This medication helps heal acid damage to the stomach and esophagus, helps prevent ulcers and is expected to help prevent cancer of the esophagus.
The product will be manufactured at the group's formulation manufacturing facility in Moraiya, Ahmedabad, Zydus Lifesciences said.
As per IQVIA MAT April 2023 data, Esomeprazole Magnesium for Delayed-Release Oral Suspension (20 mg and 40 mg) had annual sales of USD 42 million in the US.
Shares of Zydus Lifesciences ended 0.16 per cent down at Rs 514.20 apiece on the BSE.
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.
RECOMMENDED STORIES
lok-sabha-elections-2024-final phase-7 voting-date-last day to vote general election timings-states-seats-key-candidates-constituencies-ls-polls-general-election-schedule-time-table-results-date
From Axis to IDFC First - These bank stocks can give bumper returns in 3-4 weeks – Check target price and stop loss
Rules Changing from June 1: Aadhaar card update, driving license, LPG price and others - Check Full List
Central Railways' 63-hour mega block to hit Mumbai local train services, check dates and other details
SBI Senior Citizen FD Interest Rates 2024: What Rs 2 lakh, Rs 4 lakh, and 6 lakh, and Rs 8 lakh investments will give you in 1-, 3-, and 5-year FDs
Gold and Silver rate today (May 30, 2024): Precious metal futures trade in red; yellow metal near Rs 72,000, white metal falls by nearly Rs 1,500
08:10 PM IST